Wakamoto Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -11.33% vs 32.28% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -96.51% vs 1,463.67% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,596.40",
          "val2": "2,928.20",
          "chgp": "-11.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "182.00",
          "val2": "494.40",
          "chgp": "-63.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "0.20",
          "chgp": "450.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.20",
          "val2": "349.10",
          "chgp": "-96.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.10%",
          "val2": "131.00%",
          "chgp": "-10.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 252.80% vs -40.92% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,906.80",
          "val2": "7,789.50",
          "chgp": "27.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "626.20",
          "val2": "-94.60",
          "chgp": "761.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "0.90",
          "chgp": "111.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "227.20",
          "val2": "64.40",
          "chgp": "252.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.80%",
          "val2": "-58.80%",
          "chgp": "8.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

2,596.40

2,928.20

-11.33%

Operating Profit (PBDIT) excl Other Income

182.00

494.40

-63.19%

Interest

1.10

0.20

450.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

12.20

349.10

-96.51%

Operating Profit Margin (Excl OI)

26.10%

131.00%

-10.49%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -11.33% vs 32.28% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -96.51% vs 1,463.67% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

9,906.80

7,789.50

27.18%

Operating Profit (PBDIT) excl Other Income

626.20

-94.60

761.95%

Interest

1.90

0.90

111.11%

Exceptional Items

0.00

-1.30

100.00%

Consolidate Net Profit

227.20

64.40

252.80%

Operating Profit Margin (Excl OI)

25.80%

-58.80%

8.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 252.80% vs -40.92% in Mar 2025

All Annual Results